Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AEMDthis companyAethlon Medical, Inc.	$5.41	-1.03×	1.51×	0×	-0.39×	21.8%	0.0%	0.0%	0.0%	-146.4%	-139.6%	-95.0%	0.07×	0.69×	-507.49×	3.85×	0.0%	1	-40.86	3	B-
CODXCo-Diagnostics, Inc.	$0.27	-0.14×	0.33×	10.83×	0.08×	1999.8%	64.3%	-5025.5%	-7533.6%	-227.3%	-138.3%	-442.4%	0.06×	0.22×	0×	3.87×	0.0%	2	-17.12	3	B-
ERNAErnexa Therapeutics Inc.	$1.93	-0.54×	3.15×	0×	-0.45×	-4.7%	0.0%	0.0%	0.0%	-586.6%	-316.6%	-93.2%	0.2×	0.1×	-345.15×	1.01×	0.0%	2	-64.61	2	B-
NVNOenVVeno Medical Corporation	$6.52	-0.34×	0.25×	0×	-0.23×	-49.7%	0.0%	0.0%	0.0%	-71.8%	-75.1%	-231.9%	0.03×	0.12×	0×	13.58×	0.0%	1	-13.74	3	B-
TNONTenon Medical, Inc.	$1.71	-0.56×	1.39×	1.78×	-0.28×	-116666.0%	59.8%	-324.3%	-318.4%	-249.1%	-166.4%	-156.8%	0.03×	0.3×	0×	2.11×	0.0%	3	-16.68	2	C
VVOSVivos Therapeutics, Inc.	$0.09	-0.99×	-14×	1.2×	-1.62×	-32523.0%	60.4%	-114.1%	-121.7%	1424.8%	-123.1%	-84.4%	-9.06×	-0.58×	0×	0.24×	0.0%	3	-11.29	2	C
Peer median	—	-0.54×	0.33×	1.2×	-0.28×	-49.7%	59.8%	-114.1%	-121.7%	-227.3%	-138.3%	-156.8%	0.03×	0.12×	0×	2.11×	0.0%	2	-16.68	2	—